In 2003, the Food and Drug Administration (FDA) approved a newer selective MAOI called ________ for treating Parkinson's disease.

Question

Quizplus · Accepted Answer

Selegiline is a selective MAOI that is FDA-approved for treating Parkinson's disease. Doxepin and phenelzine are also MAOIs, but they are not selective and can have more side effects. Sertraline is a selective serotonin reuptake inhibitor (SSRI) and is not an MAOI.

In 2003, the Food and Drug Administration (FDA) Approved a Newer